Mankind Pharma Acquires Roche’s Rivotril Brand to Strengthen CNS Portfolio in India
In a strategic move, Mankind Pharma has acquired the rights of Roche’s Rivotril brand in India. The deal strengthens its presence in CNS therapies and is expected to improve availability and affordability of clonazepam for patients with epilepsy and related conditions.







